BIOLASE, Inc.
BIOLQ
$0.0078
$0.00034.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -16.04M | -19.20M | -21.27M | -20.63M | -25.17M |
| Total Depreciation and Amortization | 2.62M | 2.54M | 3.31M | 2.80M | 2.26M |
| Total Amortization of Deferred Charges | 1.30M | 1.51M | 1.72M | 873.00K | 1.77M |
| Total Other Non-Cash Items | -645.00K | 589.00K | 1.66M | 1.85M | 2.78M |
| Change in Net Operating Assets | -660.00K | 3.02M | 210.00K | 1.03M | 972.00K |
| Cash from Operations | -13.43M | -11.54M | -14.37M | -14.09M | -17.39M |
| Capital Expenditure | -252.00K | -394.00K | -724.00K | -1.31M | -1.60M |
| Sale of Property, Plant, and Equipment | 540.00K | 466.00K | 379.00K | 182.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 288.00K | 72.00K | -345.00K | -1.13M | -1.60M |
| Total Debt Issued | 2.50M | -- | -- | -- | -- |
| Total Debt Repaid | -1.03M | -1.03M | -330.00K | -165.00K | 0.00 |
| Issuance of Common Stock | 3.84M | 3.84M | 3.94M | 9.67M | 8.62M |
| Repurchase of Common Stock | -10.00K | -- | -- | -- | -32.00K |
| Issuance of Preferred Stock | 270.00K | 3.20M | 6.19M | 6.19M | 6.19M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 3.02M | 3.85M | 4.76M | 1.74M | 1.74M |
| Cash from Financing | 8.59M | 9.86M | 14.56M | 17.43M | 16.52M |
| Foreign Exchange rate Adjustments | 180.00K | -47.00K | 13.00K | 171.00K | 319.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.37M | -1.66M | -139.00K | 2.39M | -2.15M |
